Lipid‐Altering Efficacy and Safety of Simvastatin 80 mg/Day: Long‐Term Experience in a Large Group of Patients with Hypercholesterolemia

Background: Elevated levels of low‐density lipoprotein (LDL) cholesterol promote the development of atherosclerosis and coronary heart disease. Hypothesis: Simvastatin 80 mg/day will be more effective than simvastatin 40 mg/day at reducing LDL cholesterol and will be well tolerated. Methods: Two sim...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Cardiol
Hlavní autoři: Ose, Leiv, Davidson, Michael H., Insull, William, Wu, Mei, Tate, Ann C., Melino, Michael R., Mercuri, Michele, Mitchel, Yale B., Stein, Evan A., Kastelein, Johannes J. P., Scott, Russell S., Hunninghake, Donald B., Campodonico, Santiago, Escobar, Ivan D., Stepanavage, Michael E., Schrott, Helmut G.
Médium: Artigo
Jazyk:Inglês
Vydáno: Wiley Periodicals, Inc. 2009
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6654890/
https://ncbi.nlm.nih.gov/pubmed/10680028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960230108
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky